Search Results 741-750 of 187748 for Cancer
... cancer, the results of which they published in a 2024 issue of Cancers. They found IORT safe and viable, given that surgeons thoughtfully selected patients ...
Investigators in the Mayo Clinic Ovarian Cancer SPORE are exploring natural killer (NK) cells as an adoptive cellular therapy for ovarian cancer.
Lynch syndrome (LS) is a hereditary cancer predisposition syndrome caused by inactivating mutations in DNA mismatch repair (MMR) genes.
Learn about the risks and results of this procedure, which is used to deliver radiation therapy for prostate cancer.
... cancer, in patients whose cancer has spread or cannot be removed by surgery. This medicine is also used in combination with everolimus to treat advanced ...
The skeletal effects of cancer-associated bone loss have become more important due to improved patient survival rates and longevity.
These cancers start in germ-fighting white blood cells called B cells. B cells also are called B lymphocytes. Treatment for B-cell lymphomas may include a " ...
"We included a variety of different types of cancer, including solid tumors and hematologic malignancies." Humoral response for various cancers and therapies.
The cancer cells spread out in the tissue, so healthcare professionals say they are diffuse. DLBCL is a fast-growing cancer. However, it can often be treated ...
This treatment also is called androgen deprivation therapy (ADT). Most prostate cancer cells need testosterone to grow. ADT stops testosterone from being made ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.